|
|
Volumn 278, Issue 2, 2010, Pages 161-164
|
|
The future of biomarkers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTICOAGULANT AGENT;
ANTIDIABETIC AGENT;
ANTIOXIDANT;
ANTIVITAMIN K;
ASCORBIC ACID;
BIOLOGICAL MARKER;
CYCLIN DEPENDENT KINASE 2;
CYTOCHROME P450 2C9;
DICLOFENAC;
ETOPOSIDE;
FATTY ACID SYNTHASE;
LOSARTAN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXIDOREDUCTASE;
PHENYTOIN;
PLANT EXTRACT;
RNA;
SULFONYLUREA;
TOLBUTAMIDE;
VACCINE;
WARFARIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ALLELE;
APOPTOSIS;
CAG REPEAT;
CARCINOGENESIS;
CD4+ T LYMPHOCYTE;
CELL GROWTH;
CHRONIC DISEASE;
DEGENERATIVE DISEASE;
DISEASE COURSE;
DNA DAMAGE;
DNA REPAIR;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG RESPONSE;
EDITORIAL;
ELEUTHEROCOCCUS SENTICOSUS;
ENVIRONMENTAL STRESS;
ENZYME ACTIVITY;
EPIGENETICS;
ETHNIC GROUP;
EXERCISE;
GENE EXPRESSION;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
HELA CELL;
HEPATITIS B;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUNTINGTON CHOREA;
IMMUNE RESPONSE;
INFLUENZA;
LIPID PEROXIDATION;
MEASLES;
MUMPS;
NONHUMAN;
OXIDATIVE STRESS;
PHARMACOGENOMICS;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RUBELLA;
SMOKING;
ANIMALS;
BIOLOGICAL MARKERS;
BIOMARKERS, PHARMACOLOGICAL;
DRUG DESIGN;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PHARMACOGENETICS;
|
|
EID: 78149471510
PISSN: 0300483X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.tox.2010.09.015 Document Type: Editorial |
|
Times cited : (4)
|
|
References (6)
|
